Lupin rolls out generic BromSite
Generic BromSite is indicated for the treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery.
Lupin is offering Bromfenac Ophthalmic Solution, 0.075%, which is a generic of Sun Pharmaceutical’s BromSite.
The medication is indicated for the treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery.
[Read more: Lupin receives FDA OK for generic Banzel]
Bromfenac Ophthalmic Solution 0.075% had a market value of roughly $15 million, per IQVIA December 2023 data.